Literature DB >> 12384318

Local drug delivery to the brain.

Paul P Wang1, James Frazier, Henry Brem.   

Abstract

The controlled local delivery of antineoplastic agents by biodegradable polymers is a technique that allows for exposure of tumor cells to therapeutic doses of an active agent for prolonged periods of time while avoiding high systemic doses associated with debilitating toxicities. The use of polymers for chemotherapy delivery expands the spectrum of available treatment of neoplasms in the central nervous system, and facilitates new approaches for the treatment of malignant gliomas. In this article, we discuss the rationale and history of the development and use of these polymers, and review the various agents that have used this technology to treat malignant brain tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384318     DOI: 10.1016/s0169-409x(02)00054-6

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  29 in total

Review 1.  Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review.

Authors:  Susmita Bose; Solaiman Tarafder
Journal:  Acta Biomater       Date:  2011-11-20       Impact factor: 8.947

2.  In Vitro Degradation of an Aromatic Polyanhydride with Enhanced Thermal Properties.

Authors:  Sabrina S Snyder; Theodore J Anastasiou; Kathryn E Uhrich
Journal:  Polym Degrad Stab       Date:  2015-05-01       Impact factor: 5.030

3.  Drug-triggered and cross-linked self-assembling nanofibrous hydrogels.

Authors:  Vivek A Kumar; Siyu Shi; Benjamin K Wang; I-Che Li; Abhishek A Jalan; Biplab Sarkar; Navindee C Wickremasinghe; Jeffrey D Hartgerink
Journal:  J Am Chem Soc       Date:  2015-04-01       Impact factor: 15.419

Review 4.  Biomaterials for the central nervous system.

Authors:  Yinghui Zhong; Ravi V Bellamkonda
Journal:  J R Soc Interface       Date:  2008-09-06       Impact factor: 4.118

5.  Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate.

Authors:  Silke Glage; Andrew L Lewis; Patricia Mertens; Steffen Baltes; Peter Geigle; Thomas Brinker
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

6.  Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol).

Authors:  William J Bodell; Alexander P Bodell; Donald D Giannini
Journal:  Neuro Oncol       Date:  2006-10-03       Impact factor: 12.300

7.  Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.

Authors:  Emilie Allard; Delphine Jarnet; Anne Vessières; Sandrine Vinchon-Petit; Gérard Jaouen; Jean-Pierre Benoit; Catherine Passirani
Journal:  Pharm Res       Date:  2009-11-12       Impact factor: 4.200

8.  Interstitial continuous infusion therapy in a malignant glioma model in rats.

Authors:  Yuichi Tange; Akihide Kondo; Merrill J Egorin; Barbara Mania-Farnell; Georgy M Daneriallis; Hiromichi Nakazaki; Simone T Sredni; Veena Rajaram; Stewart Goldman; Marcelo B Soares; Tadanori Tomita
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

9.  Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.

Authors:  Ruman Rahman; Stuart Smith; Cheryl Rahman; Richard Grundy
Journal:  J Oncol       Date:  2010-04-11       Impact factor: 4.375

10.  In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy.

Authors:  Sandrine Vinchon-Petit; Delphine Jarnet; Archibald Paillard; Jean-Pierre Benoit; Emmanuel Garcion; Philippe Menei
Journal:  J Neurooncol       Date:  2009-09-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.